Related Experiment Videos

STAT1-S727 - the license to kill

Eva M Putz1, Dagmar Gotthardt1, Veronika Sexl1

  • 1Institute of Pharmacology and Toxicology; University of Veterinary Medicine Vienna ; Vienna, Austria.

Oncoimmunology
|May 6, 2015
PubMed

Insights

Cyclin-dependent kinase 8 (CDK8) phosphorylates signal transducer and activator of transcription 1 (STAT1), inhibiting natural killer cell activity. This suggests CDK8 is a potential target for cancer immunotherapy.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Serine phosphorylation is crucial for STAT protein transcriptional activity.
  • Signal transducer and activator of transcription 1 (STAT1) plays a role in immune responses.
  • Natural killer (NK) cells are critical for tumor surveillance.

Purpose of the Study:

  • To investigate the role of CDK8-mediated phosphorylation of STAT1 on S727.
  • To determine the impact of this phosphorylation on NK cell cytotoxicity and tumor surveillance.
  • To evaluate CDK8 as a potential therapeutic target in immunotherapy.

Main Methods:

  • Analysis of STAT1 phosphorylation at S727.
  • Assessment of NK cell cytotoxicity assays.
  • Evaluation of tumor surveillance in relevant models.

Main Results:

  • CDK8-mediated phosphorylation of STAT1 on S727 was identified.
  • This specific phosphorylation was found to inhibit NK cell cytotoxicity.
  • The phosphorylation was also shown to restrain tumor surveillance, indicating a suppressive role.

Conclusions:

  • CDK8-mediated STAT1 phosphorylation at S727 acts as a negative regulator of anti-tumor immunity.
  • Targeting CDK8 may enhance NK cell-mediated tumor surveillance and improve immunotherapy outcomes.
Keywords:
CDK, cyclin-dependent kinaseCDK8CTLA-4, cytotoxic T lymphocyte antigen 4FDA, food and drug administrationKLRG1, killer cell lectin-like receptor subfamily G member 1MHC, major histocompatibility complexNK cellsNK, natural killerPD-1, programmed cell death 1STAT1STAT1, signal transducer and activator of transcription 1immunotherapytumor immune surveillance

Related Concept Videos